ARTICLE | Clinical News
Cannabidiol: Phase II started
August 22, 2016 7:00 AM UTC
Insys said investigators began a double-blind, placebo-controlled, Canadian Phase II trial to evaluate 400 mg oral CBD for 2 days followed by 800 mg CBD for 92 days in about 110 cocaine-dependent pati...